A Convergent Mixed-methods Study of the User Perspectives for an Individualized, Computerized, Collaboratively Produced, Evidence-based Patient Self-administered Systemic Lupus Erythematosus Decision Aid.

J Clin RheumatolJul 29, 2026 (epub)
Clinical ResearchRheumatology

Jasvinder A Singh, Haiyan Qu

✦ AI-curated · Sources linked

In 30 seconds

This multicenter mixed-methods study evaluated patient feedback on a computerized decision aid for systemic lupus erythematosus (SLE) across 15 US rheumatology clinics from 2019 to 2023. Among 1895 patients, 78% to 92% rated the information quality as good to excellent, indicating high acceptability and usefulness in therapy decision-making.

Key findings

  • 78% to 92% of patients rated the information quality of the SLE PtDA as good to excellent.
  • 82% of participants felt the amount of information was just right.
  • 90% found the SLE PtDA useful for making therapy decisions.
  • 82% reported that the presentation of data was balanced.

Why it matters

Understanding patient perspectives on decision aids can enhance their design and effectiveness, ultimately improving patient engagement and satisfaction in managing chronic conditions like SLE.

Source

Published in J Clin Rheumatol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Rheumatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.